Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

359
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
359
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

332
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
332
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

146
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
146
Hypertension I: Introduction01:28

Hypertension I: Introduction

504
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
504
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

309
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
309
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship between amyloid choroidopathy and neurological involvement severity scores in transthyretin amyloidosis.

Journal francais d'ophtalmologie·2025
Same author

OGG1 activation improves T cell resilience to oxidative stress after allo-SCT and T cell engager exposure.

Leukemia·2025
Same author

Spectral characterization of intraoperative renal perfusion using hyperspectral imaging and artificial intelligence.

Scientific reports·2024
Same author

Haze factor of silver nanowires in variable refractive index environment: experimental and simulation approaches.

Nanotechnology·2024
Same author

[HYPNOSTRESS study: Interest of medical hypnosis in the evaluation of perceived stress and the experience of hospitalization in an internal medicine department].

La Revue de medecine interne·2024
Same author

Large-vessel involvement in ANCA-associated vasculitis: A multicenter case-control study.

Seminars in arthritis and rheumatism·2024

Related Experiment Video

Updated: Dec 2, 2025

Knee Arthrocentesis in Adults
04:41

Knee Arthrocentesis in Adults

Published on: February 25, 2022

8.6K

[Secondary ITP in adults].

M Michel1, J-C Lega2, L Terriou3

  • 1Service de médecine interne, centre de référence pour les cytopénies auto-immunes de l'adulte, CHU Henri-Mondor, université Paris Est Créteil, Assistance publique-Hôpitaux de Paris, Créteil, France.

La Revue De Medecine Interne
|November 3, 2020
PubMed
Summary
This summary is machine-generated.

Secondary immune thrombocytopenia (ITP) in adults requires identifying underlying causes like lymphomas or autoimmune diseases. Treatment must address these specific conditions alongside standard ITP management for better outcomes.

Keywords:
Chronic lymphocytic leukemiaDéficit immunitaire commun variableImmunological thrombocytopenic purpuraLeucémie lymphoïde chroniqueLupus systémiquePTI secondairesPurpura thrombopénique immunologiqueSecondary ITPSystemic lupusVariable common immune deficiency

More Related Videos

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.3K
Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

735

Related Experiment Videos

Last Updated: Dec 2, 2025

Knee Arthrocentesis in Adults
04:41

Knee Arthrocentesis in Adults

Published on: February 25, 2022

8.6K
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.3K
Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

735

Area of Science:

  • Hematology
  • Immunology

Background:

  • Secondary immune thrombocytopenia (ITP) accounts for about 20% of adult cases, increasing with age.
  • Identifying secondary causes is crucial as they impact prognosis, outcome, and management strategies.

Purpose of the Study:

  • To emphasize the necessity of a minimal workup for secondary ITP to detect associated or underlying conditions.
  • To highlight common causes of secondary ITP in adults.

Main Methods:

  • Review of existing literature and clinical guidelines on secondary ITP.
  • Analysis of common etiologies and their clinical implications.

Main Results:

  • Frequent causes of secondary ITP in adults include B-cell lymphomas (especially chronic lymphocytic leukemia), systemic autoimmune diseases (e.g., systemic lupus), and primary immunodeficiencies (e.g., common variable immunodeficiency).

Conclusions:

  • While initial treatment for secondary ITP often mirrors primary ITP (corticosteroids ± IVIg), subsequent therapies must be tailored to the specific underlying condition.
  • A thorough diagnostic workup is essential for effective, individualized management of secondary ITP.